Inhibition of drug metabolizing enzyme catalytic activity is a leading mechanism of drug-drug interactions. In vitro enzyme inhibition studies are valuable tools to predict the clinical drug-drug interaction potential of NCEs.
Gentest® Research Services utilizes pooled human liver microsomes (UltraPool HLM150 ) as well as cDNA expressed individual enzymes (Supersomes™) to deliver robust, reproducible results. The combination of proprietary products, regulatory guidance driven protocols and highly experienced study directors provides clients with reliable, submission-ready results.
ISCT 2024
Vancouver Convention Centre 1055 Canada Pl, Vancouver, British Columbia, CanadaJoin Discovery Life Sciences at ISCT 2024 Stop by our booth #453 or schedule a meeting with our CGT team. May 28- 31, 2024 | Vancouver, Canada Schedule a […]